AR
CSII

Advisory Research’s Cardiovascular Systems, Inc. CSII Stock Holding History

Advisory Research’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-25,338
Closed -$1.2M – 361
2019
Q3 		$1.2M Buy
+25,338
New +$1.19M 0.06% 173

Other funds holding CSII

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Advisory Research's CSII Position: Q4 2019 in Review

Advisory Research sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2019, closing a stake of 25,338 shares — an estimated $1.2M sold.

Advisory Research first reported a position in CSII in Q3 2019 and held it in 1 quarter. The position peaked at $1.2M in Q3 2019. 189 funds tracked by Wall St. Rank hold CSII as of Q4 2019.

  • Advisory Research reported no remaining Cardiovascular Systems, Inc. position as of Q4 2019 after selling out during the quarter.
  • Advisory Research sold 25,338 Cardiovascular Systems, Inc. shares in Q4 2019, an estimated $1.2M.
  • Advisory Research first reported a position in Cardiovascular Systems, Inc. in Q3 2019 and held it in 1 quarter.
  • Advisory Research's Cardiovascular Systems, Inc. position peaked at $1.2M in Q3 2019.
  • 189 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2019.

Based on Advisory Research's 13F filing for Q4 2019, filed 11 Feb 2020.